USA:

Europe:

Email:

Consultation

PE Anti-Human CD154 (24-31)

  • Product Information
  • Description
Catalog: C-FC-4785A
Product Type: FCM Antibody
Size: 10 µl/test
Reactivity: Human, Non-human primates
Positive FC: mouse lymphoid cells
Recommended dilution: This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Analysis mode: FC
Host: Mouse
Isotype: Mouse IgG1
Alternate names: CD154, CD40 L, CD40 ligand, CD40L, CD40LG, gp39, hCD40L, HIGM1, IGM, IMD3, T BAM, T cell antigen Gp39, TNF related activation protein, TNFSF5, TRAP
Storage: 2-8°C
Purification method: The purified antibody is conjugated with R-phycoerythrin (PE) under optimum conditions. The conjugate is purified by size-exclusion chromatography.
Immunogen: human CD154 fusion protein
Genn_ID: 21947
Gene accession: BC119225
Gene symbol: Cd40lg
Buffer: PBS with 0.1% sodium azide.

The CD40 ligand (CD40L, TRAP, CD154), a member of the TNF superfamily of ligands, is expressed as either a 33-kd transmembrane homologue or 18-kd soluble form (sCD154). CD40L is primarily expressed on activated CD4+ T cells and on a small proportion of CD8+ T cells and platelets. It binds to CD40 on antigen-presenting cells (APC), which leads to many effects depending on the target cell type. It has been suggested that CD40/CD40L interactions regulate oxidative stress and affect various signaling pathways in both the immunological and the cardiovascular systems. The CD40/CD40L system is also involved in tumorigenesis. Its expression is tightly regulated, and abnormal levels of CD40L are associated with the pathogenesis of atheromatous plaque destabilization and thrombotic events. Multiple mutations in CD40LG gene have been identified that are associated with hyper-IgM immunodeficiency syndrome type 1.

Verification Code
top

We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy

Accept Cookies
x